322 related articles for article (PubMed ID: 17337085)
1. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Yang M; Choi Y; Hwangbo B; Lee JS
Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
[TBL] [Abstract][Full Text] [Related]
3. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
Zhu R; Xia Z
Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
[TBL] [Abstract][Full Text] [Related]
4. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
[TBL] [Abstract][Full Text] [Related]
5. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk.
Reszka E; Wasowicz W
Int J Occup Med Environ Health; 2001; 14(2):99-113. PubMed ID: 11548073
[TBL] [Abstract][Full Text] [Related]
6. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility.
Reszka E; Wasowicz W; Gromadzinska J
Br J Nutr; 2006 Oct; 96(4):609-19. PubMed ID: 17010218
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer: role of polymorphisms in biotransformation enzymes.
Sarmanová J; Sůsová S; Gut I; Mrhalová M; Kodet R; Adámek J; Roth Z; Soucek P
Eur J Hum Genet; 2004 Oct; 12(10):848-54. PubMed ID: 15280903
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
[TBL] [Abstract][Full Text] [Related]
11. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
12. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to pre-eclampsia is associated with multiple genetic polymorphisms in maternal biotransformation enzymes.
Zusterzeel PL; Peters WH; Burton GJ; Visser W; Roelofs HM; Steegers EA
Gynecol Obstet Invest; 2007; 63(4):209-13. PubMed ID: 17167268
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.
Wormhoudt LW; Commandeur JN; Vermeulen NP
Crit Rev Toxicol; 1999 Jan; 29(1):59-124. PubMed ID: 10066160
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in benzene metabolism and susceptibility to multiple myeloma.
Lincz LF; Scorgie FE; Robertson R; Enno A
Leuk Res; 2007 Jun; 31(6):759-63. PubMed ID: 16949155
[TBL] [Abstract][Full Text] [Related]
16. [Role of xenobiotic biotransformation enzymes in respiratory diseases caused by dust].
Mingazova SR; Viktorova TV; Akhmadishina LZ
Med Tr Prom Ekol; 2009; (11):30-3. PubMed ID: 20095411
[TBL] [Abstract][Full Text] [Related]
17. Genetic predisposition and treatment-related leukemia.
Perentesis JP
Med Pediatr Oncol; 2001 May; 36(5):541-8. PubMed ID: 11340609
[TBL] [Abstract][Full Text] [Related]
18. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
Dolzan V; Rudolf Z; Breskvar K
Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
